OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Low mutational load in pediatric medulloblastoma still translates into neoantigens as targets for specific T-cell immunotherapy
Franziska Blaeschke, Milan Paul, Martin U. Schuhmann, et al.
Cytotherapy (2019) Vol. 21, Iss. 9, pp. 973-986
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Exploring immunotherapy in colorectal cancer
Junyong Weng, Shanbao Li, Zhonglin Zhu, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 224

Beyond Tumor Mutation Burden: Tumor Neoantigen Burden as a Biomarker for Immunotherapy and Other Types of Therapy
Peipei Wang, Yueyun Chen, Chun Wang
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 93

Neoantigens in cancer immunotherapy: focusing on alternative splicing
Peng Huang, Feng Wen, Nuerye Tuerhong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11

Significance of Gelsolin Superfamily Genes in Diagnosis, Prognosis and Immune Microenvironment Regulation for Endometrial Cancer
Senwei Jiang, Minjuan Ye, Jing Wan, et al.
Cancer Medicine (2025) Vol. 14, Iss. 4
Open Access | Times Cited: 1

Alternative RNA splicing defects in pediatric cancers: new insights in tumorigenesis and potential therapeutic vulnerabilities
Akila S. Venkataramany, Kathleen M. Schieffer, K Lee, et al.
Annals of Oncology (2022) Vol. 33, Iss. 6, pp. 578-592
Open Access | Times Cited: 25

Neoantigen Cancer Vaccines: Generation, Optimization, and Therapeutic Targeting Strategies
Carson R. Reynolds, Son Tran, Mohit Jain, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 196-196
Open Access | Times Cited: 24

<p>Immunotherapy for Medulloblastoma: Current Perspectives</p>
Tanvir Kabir, Charles A. Kunos, John L. Villano, et al.
ImmunoTargets and Therapy (2020) Vol. Volume 9, pp. 57-77
Open Access | Times Cited: 38

Proteogenomic discovery of neoantigens facilitates personalized multi-antigen targeted T cell immunotherapy for brain tumors
Samuel Rivero-Hinojosa, Melanie Grant, Aswini K. Panigrahi, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 32

Coming in from the cold: overcoming the hostile immune microenvironment of medulloblastoma
Tanja Eisemann, Robert J. Wechsler‐Reya
Genes & Development (2022) Vol. 36, Iss. 9-10, pp. 514-532
Open Access | Times Cited: 20

Ubiquitination in lipid metabolism reprogramming: implications for pediatric solid tumors
Weixin Zhang, Yile Xu, Yapeng Fang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

The Tumor Microenvironment of Medulloblastoma: An Intricate Multicellular Network with Therapeutic Potential
Niek van Bree, Margareta Wilhelm
Cancers (2022) Vol. 14, Iss. 20, pp. 5009-5009
Open Access | Times Cited: 16

Cellular immunotherapy for medulloblastoma
Michael Y. Schakelaar, Matthijs Monnikhof, Sandra Crnko, et al.
Neuro-Oncology (2022) Vol. 25, Iss. 4, pp. 617-627
Open Access | Times Cited: 15

Tumor Neoepitope-Based Vaccines: A Scoping Review on Current Predictive Computational Strategies
Luiz Gustavo do Nascimento Rocha, Paul Anderson Souza Guimarães, Maria Gabriela Reis Carvalho, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 836-836
Open Access | Times Cited: 2

Immune cell landscape and immunotherapy of medulloblastoma
Jin Zhang, Tianyou Wang
Pediatric Investigation (2021) Vol. 5, Iss. 4, pp. 299-309
Open Access | Times Cited: 15

Pyroptosis impacts the prognosis and treatment response in gastric cancer via immune system modulation.
Wanli Yang, Liaoran Niu, Xinhui Zhao, et al.
PubMed (2022) Vol. 12, Iss. 4, pp. 1511-1534
Closed Access | Times Cited: 11

Immunobiology and Cytokine Modulation of the Pediatric Brain Tumor Microenvironment: A Scoping Review
Shreya Budhiraja, Hinda Najem, Shashwat Tripathi, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3655-3655
Open Access | Times Cited: 6

Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion
Sara A. Byron, William P.D. Hendricks, Abhinav B. Nagulapally, et al.
Cancer Research (2021) Vol. 81, Iss. 23, pp. 5818-5832
Open Access | Times Cited: 14

Role of DNMTs in the Brain
Can Bora Yildiz, Geraldine Zimmer‐Bensch
Advances in experimental medicine and biology (2022), pp. 363-394
Closed Access | Times Cited: 9

A Novel Proteogenomic Integration Strategy Expands the Breadth of Neo-Epitope Sources
Haitao Xiang, Le Zhang, Fanyu Bu, et al.
Cancers (2022) Vol. 14, Iss. 12, pp. 3016-3016
Open Access | Times Cited: 8

Identifying and clinically validating biomarkers for immunotherapy in colorectal cancer
Yung‐Sung Yeh, Hsiang‐Lin Tsai, Po-Jung Chen, et al.
Expert Review of Molecular Diagnostics (2023) Vol. 23, Iss. 3, pp. 231-241
Closed Access | Times Cited: 4

Roles and interactions of tumor microenvironment components in medulloblastoma with implications for novel therapeutics
H. Yang, Min Li, Yu‐Hao Deng, et al.
Genes Chromosomes and Cancer (2024) Vol. 63, Iss. 4
Closed Access | Times Cited: 1

Medulloblastoma targeted therapy: From signaling pathways heterogeneity and current treatment dilemma to the recent advances in development of therapeutic strategies
Qiyue Wang, Xiaofei Xin, Qihao Dai, et al.
Pharmacology & Therapeutics (2023) Vol. 250, pp. 108527-108527
Closed Access | Times Cited: 3

Medulloblastoma epigenetics and the path to clinical innovation
Amanda R. Haltom, Stephanie Toll, Donghang Cheng, et al.
Journal of Neuro-Oncology (2020) Vol. 150, Iss. 1, pp. 35-46
Open Access | Times Cited: 7

Efficacy of Intranodal Neoantigen Peptide-pulsed Dendritic Cell Vaccine Monotherapy in Patients With Advanced Solid Tumors: A Retrospective Analysis
Takashi Morisaki, Takafumi Morisaki, Makoto Kubo, et al.
Anticancer Research (2021) Vol. 41, Iss. 8, pp. 4101-4115
Open Access | Times Cited: 6

Page 1 - Next Page

Scroll to top